Perspective
When Cost-Effectiveness Thresholds Drift: Global HTA, MFN Pricing, and the Need for a Coherent Framework
May 28, 2026
Featured Experts: William Padula, PhD
Research
All Research Featured Research
Comment Letter
Comments on Proposed GLOBE and GUARD Models
February 27, 2026
Featured Experts: Alice Chen, PhD, Darius Lakdawalla, PhD, Barry Liden, JD
Comment Letter
Response to the Draft Report of the Health Economics Methods Advisory (HEMA): “Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies”
October 21, 2025
Featured Experts: Alice Chen, PhD, Jason Doctor, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Karen Mulligan, PhD, Desi Peneva, MS, Charles E. Phelps, PhD
News
USC Health Economist Darius Lakdawalla Elected to National Academy of Medicine
October 20, 2025
Featured Experts: Darius Lakdawalla, PhD
Journal Article
Measuring the Budget Impact of Nondiscriminatory Cost-Effectiveness
September 5, 2025
Featured Experts: Karen Mulligan, PhD, Drishti Baid, MPP, Maria-Alice Manetas, Darius Lakdawalla, PhD
Evidence Base
A Value-Based Price for Anti-Obesity Medications
July 17, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD
Journal Article
Proposal for a Value-Based Agreement to Reimburse Anti-Obesity Medicines in Traditional Medicare
July 11, 2025
Featured Experts: Alison Sexton Ward, PhD, Erin Trish, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
News
Why Do Americans Pay More for Prescription Drugs?
June 12, 2025
Featured Experts: Darius Lakdawalla, PhD
Perspective
Medicare Drug Price Negotiations Need Something New: A Floor
January 22, 2025
Featured Experts: Darius Lakdawalla, PhD
Issue Brief
A New Healthcare Valuation Model That Puts Patients First: Generalized Risk Adjusted Cost-Effectiveness (GRACE)
April 23, 2024
Featured Experts: Darius Lakdawalla, PhD, Stephanie Hedt, MPP, Barry Liden, JD
Journal Article
A Principled Approach to Non‑Discrimination in Cost‑Effectiveness
February 27, 2024
Featured Experts: Darius Lakdawalla, PhD, Jason Doctor, PhD
Comment Letter
Response to Sen. Cassidy’s Request for Information on Improving Americans’ Access to Gene Therapies
January 19, 2024
Featured Experts: Darius Lakdawalla, PhD, Joseph Grogan, JD, Stephanie Hedt, MPP, Barry Liden, JD, Erin Trish, PhD, Karen Van Nuys, PhD
Journal Article
Risk Preferences Over Health: Empirical Estimates and Implications for Healthcare Decision-Making
August 7, 2023
Featured Experts: Karen Mulligan, PhD, Jason Doctor, PhD, Charles E. Phelps, PhD, Darius Lakdawalla, PhD
Testimony
Testimony on Policies that Inhibit Innovation and Patient Access
May 10, 2023
Featured Experts: Darius Lakdawalla, PhD
Perspective
A Strategy for Value-Based Drug Pricing Under the Inflation Reduction Act
May 4, 2023
Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD
Perspective
Alternatives to the QALY for Comparative Effectiveness Research
April 21, 2023
Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD
Comment Letter
Comments to CMS on the Inflation Reduction Act’s Drug Price Negotiation Program
April 17, 2023
Featured Experts: Dana Goldman, PhD, Charles E. Phelps, PhD, Darius Lakdawalla, PhD, Joseph Grogan, JD, Karen Van Nuys, PhD, Barry Liden, JD, William Padula, PhD
White Paper
Mitigating the Inflation Reduction Act’s Adverse Impacts on the Prescription Drug Market
April 13, 2023
Featured Experts: Dana Goldman, PhD, Joseph Grogan, JD, Darius Lakdawalla, PhD, Barry Liden, JD, Erin Trish, PhD